HRP20050156A2 - Pyrrolidine derivatives as tryptase inhibitors - Google Patents

Pyrrolidine derivatives as tryptase inhibitors

Info

Publication number
HRP20050156A2
HRP20050156A2 HR20050156A HRP20050156A HRP20050156A2 HR P20050156 A2 HRP20050156 A2 HR P20050156A2 HR 20050156 A HR20050156 A HR 20050156A HR P20050156 A HRP20050156 A HR P20050156A HR P20050156 A2 HRP20050156 A2 HR P20050156A2
Authority
HR
Croatia
Prior art keywords
pyrrolidine derivatives
tryptase inhibitors
tryptase
inhibitors
pyrrolidine
Prior art date
Application number
HR20050156A
Other languages
English (en)
Inventor
Martin Thomas
B�r Thomas
Ulrich Wolf-R�diger
P. Sommerhoff Christian
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of HRP20050156A2 publication Critical patent/HRP20050156A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
HR20050156A 2002-07-26 2005-02-18 Pyrrolidine derivatives as tryptase inhibitors HRP20050156A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02016683 2002-07-26
PCT/EP2003/008127 WO2004012731A1 (en) 2002-07-26 2003-07-24 Pyrrolidine derivatives as tryptase inhibitors

Publications (1)

Publication Number Publication Date
HRP20050156A2 true HRP20050156A2 (en) 2005-12-31

Family

ID=31197777

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050156A HRP20050156A2 (en) 2002-07-26 2005-02-18 Pyrrolidine derivatives as tryptase inhibitors

Country Status (10)

Country Link
US (1) US20050256171A1 (xx)
EP (1) EP1534267A1 (xx)
JP (1) JP2005535685A (xx)
AU (1) AU2003250162A1 (xx)
CA (1) CA2492830A1 (xx)
HR (1) HRP20050156A2 (xx)
IS (1) IS7696A (xx)
PL (1) PL372826A1 (xx)
RS (1) RS20050063A (xx)
WO (1) WO2004012731A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2468724T3 (pl) * 2006-12-21 2016-05-31 Zealand Pharma As Synteza związków pirolidynowych

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019809A1 (en) * 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors
JP4592174B2 (ja) * 1999-11-15 2010-12-01 オセ−テクノロジーズ ビーブイ インクペレットディスペンサを有するインクジェット装置

Also Published As

Publication number Publication date
JP2005535685A (ja) 2005-11-24
RS20050063A (xx) 2007-09-21
CA2492830A1 (en) 2004-02-12
IS7696A (is) 2005-02-17
EP1534267A1 (en) 2005-06-01
US20050256171A1 (en) 2005-11-17
PL372826A1 (en) 2005-08-08
WO2004012731A1 (en) 2004-02-12
AU2003250162A1 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
IL163892A0 (en) Indolylmaleimide derivatives
IL152830A0 (en) Arylmethylamine derivatives for use as tryptase inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
HK1078870A1 (en) Heterocyclic tripeptides as hepatitis c inhibitors
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) AZAARENE DERIVATIVES
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
EP1551801A4 (en) NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
IL165887A0 (en) Novel tetrahydropyridine derivatives as renin inhibitors
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
EP1532133A4 (en) NF-: B INHIBITORS
AU2003230392A8 (en) Beta-secretase inhibitors
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
HRP20050156A2 (en) Pyrrolidine derivatives as tryptase inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
GB0213488D0 (en) 2-Naphthamide derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
IL165935A (en) Vasopeptidase inhibitors
GB0224102D0 (en) Inhibitors
GB0226149D0 (en) Inhibitors

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080722

Year of fee payment: 6

OBST Application withdrawn